Search
for
Sort by
Research 121–150 of 708
- APPLICATION OF ACELLULAR GRAFTS FOR EXTENSIVE SKIN DEFECTS – A REVIEW
- Stimulation of hair regrowth in an animal model of androgenic alopecia using 2-deoxy-D-ribose
- The Role of Hormonal Imbalances in Amenorrhea
- Characterization of Soluplus/ASC-DP Nanoparticles Encapsulated with Minoxidil for Skin Targeting
- Hair today, gone tomorrow: the degradation and conservation of archaeological hair fibers
- Obstetric and Gynecologic Dermatology
- Letters to the Editor
- Notices
- Notices
- National scientific medical meeting 1996 abstracts
- The Angiosome Theory, Flap Delay, and Scalp Surgery
- Harmless Herbs? A Review of the Recent Literature
- Treatment of invasive aspergillosis with itraconazole
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice
- Bioprinting of skin constructs for wound healing
- Lupus erythematosus: systemic and cutaneous manifestations
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- Oral retinoids-present status
- Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
- Biomedical Applications of Layer‐by‐Layer Self‐Assembly for Cell Encapsulation: Current Status and Future Perspectives
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Toxic Epidermal Necrolysis
- Folliculitis decalvans: a multicentre review of 82 patients
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Management of congenital ichthyoses: European guidelines of care, part two
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Eosinophils in fibrous tracts and near hair bulbs: A helpful diagnostic feature of alopecia areata
- A locus on distal chromosome 10 (ahl4) affecting age-related hearing loss in A/J mice
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System